arrow
Y

Yoshinori Imamura

University of Fukui
H指数:24
被引数:3,053

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer

一项关于纳武利尤单抗治疗铂类耐药的复发性或转移性唾液腺癌患者的II期临床试验

2025-12-010
OA
Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes

真实世界中免疫检查点抑制剂在HPV相关和HPV非相关亚型晚期宫颈癌中的多中心研究

2025-11-260
PRE
Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group (vol 14, 1441056, 2025)

日本局部晚期头颈癌老年患者放化疗的适应症: JCOG头颈癌研究组的问卷调查 (第14卷,1441056,2025)

2025-04-100
OAAI
Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group

日本老年局部晚期头颈癌患者放化疗的适应症: JCOG头颈癌研究组的问卷调查

2025-01-080
OAAI
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial

头颈癌放化疗患者顺铂诱导急性肾损伤的风险预测模型: JCOG1008 II/III期试验的再分析

2024-07-014
PRE
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody

紫杉醇联合两周一次的西妥昔单抗治疗先前接受铂类化疗和anti-PD-1抗体治疗的复发或转移性头颈癌患者的II期试验

2024-06-014
OAAI